1. Home
  2. PRMB vs KRYS Comparison

PRMB vs KRYS Comparison

Compare PRMB & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primo Brands Corporation

PRMB

Primo Brands Corporation

HOLD

Current Price

$19.64

Market Cap

8.0B

Sector

N/A

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$350.88

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRMB
KRYS
Founded
1955
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.6B
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
PRMB
KRYS
Price
$19.64
$350.88
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$24.00
$297.60
AVG Volume (30 Days)
4.2M
208.2K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
2.49%
N/A
EPS Growth
328.57
128.00
EPS
0.26
3.62
Revenue
$6,664,000,000.00
$389,130,000.00
Revenue This Year
$2.34
$38.74
Revenue Next Year
$3.56
$32.53
P/E Ratio
$78.77
$92.22
Revenue Growth
29.34
33.94
52 Week Low
$14.36
$158.08
52 Week High
$26.21
$382.54

Technical Indicators

Market Signals
Indicator
PRMB
KRYS
Relative Strength Index (RSI) 40.96 43.09
Support Level $20.36 $331.79
Resistance Level $21.33 $371.16
Average True Range (ATR) 0.87 9.49
MACD -0.03 -2.41
Stochastic Oscillator 15.15 9.84

Price Performance

Historical Comparison
PRMB
KRYS

About PRMB Primo Brands Corporation

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: